Inserm - activities

Visuels Paris Seine - Pont des artsVisuels Paris Seine - Pont des artsVisuels Paris Seine - Pont des artsVisuels Paris Seine - Pont des arts

Covid: the epidemic likely to peak in the coming days in France, Olivier Véran thinks

As France is faced with a new major surge in new Covid-19 cases, this Monday August 23, Olivier Véran said the epidemic is likely to peak in ICU "in a few days", detailing his statements made this past July 21 at the National Assembly about a "likely epidemic peak" at the end of summer.
Visuel Paris quai de SeineVisuel Paris quai de SeineVisuel Paris quai de SeineVisuel Paris quai de Seine

Covid: “The probability to prevent hospitals from being overcrowded again is weak”

As Emmanuel Macron has revealed the strategy to exit the crisis, epidemiologist Dominique Costagliola thinks this lockdown exit is “premature”. In an interview with Le Monde released this May 5, 2021, the biostatistician explains “the probability to prevent hospitals from being overcrowded again is weak”.
Vaccin Covid, combien de temps nous immunise-t-il ? Une étude française recherche des volontairesVaccin Covid, combien de temps nous immunise-t-il ? Une étude française recherche des volontairesVaccin Covid, combien de temps nous immunise-t-il ? Une étude française recherche des volontairesVaccin Covid, combien de temps nous immunise-t-il ? Une étude française recherche des volontaires

Covid vaccine, how long does it immunize for? A French study looks for volunteers

How long does vaccine protect us from coronavirus for? To answer this question as accurately as possible, a national study is led in France in 35 medical centers. The latter wishes to recruit 10,500 volunteers for this investigation that is a world first.
Covid : les mesures renforcées décidées en mars commencent à faire effet selon l'INSERM (A REVOIR)Covid : les mesures renforcées décidées en mars commencent à faire effet selon l'INSERM (A REVOIR)Covid : les mesures renforcées décidées en mars commencent à faire effet selon l'INSERM (A REVOIR)Covid : les mesures renforcées décidées en mars commencent à faire effet selon l'INSERM (A REVOIR)

Covid: strengthened measures instated in March start to pay off, the INSERM finds

According to a study released by the INSERM – the French National Institute for Health and Medical Research – departments where strengthened Covid-19 measures were instated first are starting to pay off given the decline in contaminations.
Visuel Paris Tour Eiffel cerisiers en fleursVisuel Paris Tour Eiffel cerisiers en fleursVisuel Paris Tour Eiffel cerisiers en fleursVisuel Paris Tour Eiffel cerisiers en fleurs

Covid: “No improvement to expect” by late May in France, an INSERM epidemiologist thinks

As Emmanuel Macron has announced travel restrictions will be progressively lifted early May, INSERM epidemiologist Dominique Costagliola told France Inter that because of the current situation there is “no soon improvement to expect” or even “any decrease” by late May in the country.
Covid : un test sérologique peu couteux mis au point par un chercheur toulousainCovid : un test sérologique peu couteux mis au point par un chercheur toulousainCovid : un test sérologique peu couteux mis au point par un chercheur toulousainCovid : un test sérologique peu couteux mis au point par un chercheur toulousain

Covid: a cheap serological test developed by a Toulousian scientist

Another good news in the fight against Covid and detecting the virus… A Toulousian scientist has developed – in partnership with Oxford University – an effective and cheap serological test, enabling to find antibodies induced by the virus with basic material.
Covid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en France

Covid: would we have to get yearly booster shot against the virus?

Would Covid seasonality have us get yearly booster shot, like we do against the flu? A question INSERM scientist and infectious disease specialist Odile Launay tried to answer to this Monday March 1 on LCI.
Covid : le variant anglais pourrait devenir "dominant" en France d'ici d'ici à la mi-marsCovid : le variant anglais pourrait devenir "dominant" en France d'ici d'ici à la mi-marsCovid : le variant anglais pourrait devenir "dominant" en France d'ici d'ici à la mi-marsCovid : le variant anglais pourrait devenir "dominant" en France d'ici d'ici à la mi-mars

Covid: 50,000 daily cases by mid-March in France? Projections from Lille University Hospital

The UK Covid variant keeps on spreading across France. According to Scientific Committee member Pr. Fontanet, "if we go on this way" then the UK variant "will become dominant from circa March 1" in the country. Furthermore, hospitals are urged to move to "crisis organization". Lille University Hospital experts project likely boom in new cases by mid-March for the coming weeks. By March 20, there could be up to 50,000 new PCR+ cases per day.
Covid : le virus Sars CoV-2 circulait déjà en France en novembre 2019 selon une étudeCovid : le virus Sars CoV-2 circulait déjà en France en novembre 2019 selon une étudeCovid : le virus Sars CoV-2 circulait déjà en France en novembre 2019 selon une étudeCovid : le virus Sars CoV-2 circulait déjà en France en novembre 2019 selon une étude

Covid: the SARS-CoV-2 virus was already spreading in France in November 2019, a study says

A study released this Wednesday February 10, 2021 by scientists says that patients suffering from severe pneumopathies hospitalized in November 2019 may have been carrying SARS-CoV-2. These results go against the scenario the epidemic broke out in December 2019 in a Chinese market in Wuhan.
Covid : 90% des cas symptomatiques n'ont pas été détectés après le premier confinement selon l'InsemCovid : 90% des cas symptomatiques n'ont pas été détectés après le premier confinement selon l'InsemCovid : 90% des cas symptomatiques n'ont pas été détectés après le premier confinement selon l'InsemCovid : 90% des cas symptomatiques n'ont pas été détectés après le premier confinement selon l'Insem

Covid: 90% of symptomatic cases non detected past the first lockdown, the INSERM says

According to a study released this Tuesday December 22, 2020 the French National Institute for Health and Medical Research notices that after the first lockdown-exit episode, the French health services have been able to report only one asymptomatic case in two, and that 90% of the symptomatic cases have not been detected.
La Covid cause trois fois plus de morts que la grippe saisonnière selon l'INSERMLa Covid cause trois fois plus de morts que la grippe saisonnière selon l'INSERMLa Covid cause trois fois plus de morts que la grippe saisonnière selon l'INSERMLa Covid cause trois fois plus de morts que la grippe saisonnière selon l'INSERM

Covid three times deadlier than the seasonal flu, the INSERM says

According to a study published by the INSERM – French National Institute for Health and Medical Research – Covid has been three times deadlier than the seasonal flu. Data found after observing admissions of 130,000 patients in hospitals this spring 2020 in comparison with the 2018/2019 flu season.
Coronavirus : déjà 20 000 volontaires pour tester les vaccins en France selon l'InsermCoronavirus : déjà 20 000 volontaires pour tester les vaccins en France selon l'InsermCoronavirus : déjà 20 000 volontaires pour tester les vaccins en France selon l'InsermCoronavirus : déjà 20 000 volontaires pour tester les vaccins en France selon l'Inserm

Covid vaccine: tests on volunteers to begin in France, the French National Institute for Health and Medical Research says

French people mindful of the Covid vaccine discovery… The INSERM or French National Institute for Health and Medical Research has announced that the vaccine is about to be tested on 41,000 volunteers that signed up from mid-December, after striking several deals with three pharmaceutical companies whose candidate vaccine passed their clinical trial phases.
Coronavirus : ouvrir les fênetres, geste barrière oubliéCoronavirus : ouvrir les fênetres, geste barrière oubliéCoronavirus : ouvrir les fênetres, geste barrière oubliéCoronavirus : ouvrir les fênetres, geste barrière oublié

Coronavirus: Macron recommends to open your windows to fight against the virus

To fight against coronavirus, it is vital to air and open windows. After the call launched by doctors, Macron reminded this simple gesture. Ten minutes, three times a day are enough to cleanse the air and lower the risk of falling sick to coronavirus, even though temperatures are dropping.
Opération Cortex, l'escape game de l'INSERM à l'Institut de psychiatrie et de neurosciencesOpération Cortex, l'escape game de l'INSERM à l'Institut de psychiatrie et de neurosciencesOpération Cortex, l'escape game de l'INSERM à l'Institut de psychiatrie et de neurosciencesOpération Cortex, l'escape game de l'INSERM à l'Institut de psychiatrie et de neurosciences

Operation Cortex, INSERM's free escape game at the Institute of Psychiatry and Neuroscience

Fans of escape games will meet up at the Institute of Psychiatry and Neuroscience to discover a brand new playful and immersive adventure created by INSERM, entitled Opération Cortex, from November 15, 2019. An adventure game scheduled to run throughout France in 2020, its aim is to raise awareness of medical research, neuroscience and the research institute's involvement in the development of new therapies.
Coronavirus : des "résultats positifs" pour le traitement remdesivir/diltiazem selon l'InsermCoronavirus : des "résultats positifs" pour le traitement remdesivir/diltiazem selon l'InsermCoronavirus : des "résultats positifs" pour le traitement remdesivir/diltiazem selon l'InsermCoronavirus : des "résultats positifs" pour le traitement remdesivir/diltiazem selon l'Inserm

Coronavirus: “Positive results” for the remdesivir/diltiazem treatment the Inserm says

Searchers from the French National Institute for Health and Medical Research (Inserm) in Lyon showed that mixing two medicines, remdesivir and diltiazem, gave “positive results” for a pre-clinical phase. A new step for the discovery of an effective treatment against coronavirus.